Mannkind (MNKD) Interest & Investment Income (2010 - 2026)

Mannkind's (MNKD) quarterly Interest & Investment Income came in at $1.4 million in Q1 2026, down 26.94% year-on-year from $2.0 million in Q1 2025, and down 12.71% on a QoQ basis from $1.6 million in Q4 2025.

Mannkind (MNKD) Interest & Investment Income (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Interest & Investment Income data on file, last reported at $1.4 million in Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 26.94% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 32.42% decrease from a year earlier, with the FY2025 full-year figure at $8.1 million, down 36.16% from the prior year.
  • Interest & Investment Income for Q1 2026 stood at $1.4 million, down from $1.6 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for MNKD reached as high as $3.4 million in Q1 2024 and fell as low as $377000.0 in Q1 2022.
  • Historically, Interest & Investment Income has averaged $1.8 million across 5 years, with a median of $1.6 million in 2025.
  • Across the five-year window, Interest & Investment Income surged 12466.67% in 2022 and slumped 43.04% in 2025, its largest moves.
  • Year by year, Interest & Investment Income stood at $957000.0 in 2022, then jumped by 80.25% to $1.7 million in 2023, then surged by 63.77% to $2.8 million in 2024, then tumbled by 42.05% to $1.6 million in 2025, then slipped by 12.71% to $1.4 million in 2026.
  • Per Business Quant data, the three most recent Interest & Investment Income figures were $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 48.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 19.51 Mn
10 Mannkind 1.23 Bn 1.10 Bn 82.66 Mn 1.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.43 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 2.63 Mn
Jun 30, 2025 1.83 Mn
Mar 31, 2025 1.96 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 3.18 Mn
Jun 30, 2024 3.18 Mn
Mar 31, 2024 3.43 Mn
Dec 31, 2023 1.73 Mn
Sep 30, 2023 1.58 Mn
Jun 30, 2023 1.55 Mn
Mar 31, 2023 1.30 Mn
Dec 31, 2022 957,000.00
Sep 30, 2022 663,000.00
Jun 30, 2022 516,000.00
Mar 31, 2022 377,000.00
Dec 31, 2021 48,000.00
Sep 30, 2021 36,000.00
Jun 30, 2021 25,000.00